294 related articles for article (PubMed ID: 14506129)
21. Novel mutations in the gene encoding secreted lymphocyte antigen-6/urokinase-type plasminogen activator receptor-related protein-1 (SLURP-1) and description of five ancestral haplotypes in patients with Mal de Meleda.
Marrakchi S; Audebert S; Bouadjar B; Has C; Lefèvre C; Munro C; Cure S; Jobard F; Morlot S; Hohl D; Prud'homme JF; Zahaf A; Turki H; Fischer J
J Invest Dermatol; 2003 Mar; 120(3):351-5. PubMed ID: 12603845
[TBL] [Abstract][Full Text] [Related]
22. Palmoplantar keratoderma of the Gamborg-Nielsen type is caused by mutations in the SLURP1 gene and represents a variant of Mal de Meleda.
Zhao L; Vahlquist A; Virtanen M; Wennerstrand L; Lind LK; Lundström A; Hellström Pigg M
Acta Derm Venereol; 2014 Nov; 94(6):707-10. PubMed ID: 24604124
[TBL] [Abstract][Full Text] [Related]
23. Japanese case of Mal de Meleda with a novel missense mutation of p.Thr52Ala in the second protruding finger of secreted Ly-6/uPAR-related protein 1.
Kunisada M; Yamanishi K; Nishigori C
J Dermatol; 2019 Jul; 46(7):e235-e237. PubMed ID: 30663803
[No Abstract] [Full Text] [Related]
24. Mal de Meleda: A Focused Review.
Perez C; Khachemoune A
Am J Clin Dermatol; 2016 Feb; 17(1):63-70. PubMed ID: 26445964
[TBL] [Abstract][Full Text] [Related]
25. SLURP1 is a late marker of epidermal differentiation and is absent in Mal de Meleda.
Favre B; Plantard L; Aeschbach L; Brakch N; Christen-Zaech S; de Viragh PA; Sergeant A; Huber M; Hohl D
J Invest Dermatol; 2007 Feb; 127(2):301-8. PubMed ID: 17008884
[TBL] [Abstract][Full Text] [Related]
26. Particular Mal de Meleda phenotypes in Tunisia and mutations founder effect in the Mediterranean region.
Bchetnia M; Laroussi N; Youssef M; Charfeddine C; Ben Brick AS; Boubaker MS; Mokni M; Abdelhak S; Zili J; Benmously R
Biomed Res Int; 2013; 2013():206803. PubMed ID: 24093092
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of secreted lymphocyte antigen-6/urokinase-type plasminogen activator receptor-related peptide-1 (SLURP-1), an endogenous allosteric alpha7 nicotinic acetylcholine receptor modulator, in murine and human asthmatic conditions.
Narumoto O; Horiguchi K; Horiguchi S; Moriwaki Y; Takano-Ohmuro H; Shoji S; Misawa H; Yamashita N; Nagase T; Kawashima K; Yamashita N
Biochem Biophys Res Commun; 2010 Aug; 398(4):713-8. PubMed ID: 20621062
[TBL] [Abstract][Full Text] [Related]
28. SLURP-2: A novel cholinergic signaling peptide in human mucocutaneous epithelium.
Arredondo J; Chernyavsky AI; Jolkovsky DL; Webber RJ; Grando SA
J Cell Physiol; 2006 Jul; 208(1):238-45. PubMed ID: 16575903
[TBL] [Abstract][Full Text] [Related]
29. Mal de Meleda in Indonesia: Mutations in the SLURP1 gene appear to be ubiquitous.
Taylor JA; Bondavalli D; Monif M; Yap LM; Winship I
Australas J Dermatol; 2016 Feb; 57(1):e11-3. PubMed ID: 25557416
[TBL] [Abstract][Full Text] [Related]
30. A novel homozygous missense mutation in SLURP1 causing Mal de Meleda with an atypical phenotype.
Gruber R; Hennies HC; Romani N; Schmuth M
Arch Dermatol; 2011 Jun; 147(6):748-50. PubMed ID: 21690549
[No Abstract] [Full Text] [Related]
31. Mutations in the SLURP-1 gene underlie Mal de Meleda in three Pakistani families.
Wajid M; Kurban M; Shimomura Y; Christiano AM
J Dermatol Sci; 2009 Oct; 56(1):27-32. PubMed ID: 19692209
[TBL] [Abstract][Full Text] [Related]
32. Biological effects of SLURP-1 on human keratinocytes.
Arredondo J; Chernyavsky AI; Webber RJ; Grando SA
J Invest Dermatol; 2005 Dec; 125(6):1236-41. PubMed ID: 16354194
[TBL] [Abstract][Full Text] [Related]
33. Mal de Meleda with homozygous mutation p.G86R in SLURP-1.
Jia WX; Zhang YY; Wu YD; Li WR; Cheng P; Bu WB; Li CR
Int J Dermatol; 2020 Jun; 59(6):751-754. PubMed ID: 32048728
[No Abstract] [Full Text] [Related]
34. Amelanotic melanoma arising in an area of SLURP-1 mutated Mal de Meleda.
Arousse A; Mokni S; H'mida Ben Brahim D; Bdioui A; Aounallah A; Gammoudi R; Saidi W; Boussofara L; Ghariani N; Denguezli M; Belajouza C; Nouira R
Int J Dermatol; 2019 Aug; 58(8):966-968. PubMed ID: 30246339
[No Abstract] [Full Text] [Related]
35. [Meleda-type palmo-plantar keratoderma is caused by mutations in the gene coding the SLURP protein].
Dereure O
Ann Dermatol Venereol; 2004 Feb; 131(2):224. PubMed ID: 15026760
[No Abstract] [Full Text] [Related]
36. Identification of novel homozygous SLURP1 mutation in a Javanese family with Mal de Meleda.
Radiono S; Pramono ZAD; Oh GGK; Surana U; Widiyani S; Danarti R
Int J Dermatol; 2017 Nov; 56(11):1161-1168. PubMed ID: 29023701
[TBL] [Abstract][Full Text] [Related]
37. Mal de Meleda in a taiwanese.
Chao SC; Lai FJ; Yang MH; Lee JY
J Formos Med Assoc; 2005 Apr; 104(4):276-8. PubMed ID: 15909066
[TBL] [Abstract][Full Text] [Related]
38. SLURP-1 is mutated in Mal de Meleda, a potential molecular signature for melanoma and a putative squamous lineage tumor suppressor gene.
Bergqvist C; Kadara H; Hamie L; Nemer G; Safi R; Karouni M; Marrouche N; Abbas O; Hasbani DJ; Kibbi AG; Nassar D; Shimomura Y; Kurban M
Int J Dermatol; 2018 Feb; 57(2):162-170. PubMed ID: 29231248
[TBL] [Abstract][Full Text] [Related]
39. A novel missense mutation in the gene encoding SLURP-1 in patients with Mal de Meleda from northern Tunisia.
Charfeddine C; Mokni M; Ben Mousli R; Elkares R; Bouchlaka C; Boubaker S; Ghedamsi S; Baccouche D; Ben Osman A; Dellagi K; Abdelhak S
Br J Dermatol; 2003 Dec; 149(6):1108-15. PubMed ID: 14674887
[TBL] [Abstract][Full Text] [Related]
40. Abnormal keratinization and cutaneous inflammation in Mal de Meleda.
Kudo M; Ishiura N; Tamura-Nakano M; Shimizu T; Kamata M; Akasaka E; Nakano H; Okuma Y; Tada Y; Okochi H; Tamaki T
J Dermatol; 2020 May; 47(5):554-558. PubMed ID: 32157724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
